Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Endocrinology
•
Adrenal Disorders
Can norethindrone, depakote or olanzapine interfere with the results of the 1mg overnight dexamethasone suppression test for hypercortisolism screening?
Related Questions
What is the role of oral therapy for hypercortisolism diagnosed based on unsuppressed cortisol after 1mg dexamethasone suppression test in a normoglycemic patient who also has negative adrenal imaging?
In pregnant patients with Non Classical Congenital Adrenal hyperplasia, what factors help you determine the need for continued steroid use throughout pregnancy including labor and delivery?
Is a baseline cortisol at 0 minutes necessary to do as part of an ACTH stimulation test when performing the test in late morning or in the afternoon?
For a patient with a large pheochromocytoma, how would you evaluate for possible autonomous cortisol co-secretion prior to adrenalectomy to assess need for risk of glucocorticoid withdrawal postoperatively?
Do you recommend checking plasma metanephrine levels during adrenal venous sampling to assist in assessing lateralization in primary aldosteronism?
Would you consider prophylactic anticoagulation with a DOAC, instead of low-molecular weight heparin, in a patient with newly diagnosed Cushing's syndrome?
For patients with adrenal insufficiency who are on hydrocortisone replacement, would you recommend stress doses to cover for minor procedures such as dental work or thyroid fine-needle aspiration biopsies?
Does the imaging finding of central necrosis of an adrenal tumor, biochemically confirmed as pheochromocytoma, increase the risk of malignancy?
How do we decide between Gallium-DOTATATE PET/CT and MIBG scans when evaluating a patient for suspected pheochromocytoma?
How often do you re-screen with autoantibody testing for type 1 diabetes if the initial test is negative in a patient with primary adrenal insufficiency?
